Analysis

  • March’s top news stories

    Arrowhead Pharmaceuticals dosed the first subject in a Phase I/II clinical trial of ARO-HBV for the treatment of patients with chronic hepatitis B virus (HBV) infection, and CSL Behring started...

  • February’s top news stories

    Researchers at Johns Hopkins Bloomberg School of Public Health have revealed that the number of clinical trials being funded by the National Institutes of Health (NIH) has reduced since 2005,...